Four years after its creation: what role for the Laboratoire des Grandes Épidémies Tropicales (LAGET) in epidemic response in Chad?
Published: August 8, 2025
Abstract Views: 36
PDF: 36
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Established in 2020 at the height of the COVID-19 pandemic, the Laboratoire des Grandes Épidémies Tropicales (LAGET) was created to strengthen Chad’s capacity for diagnosis, research, and training in the face of emerging infectious diseases. Four years later, this narrative review retraces the laboratory’s main achievements, from its initial structuring to its operational role in epidemic response. Through scientific publications, strategic partnerships, and its commitment to integrated surveillance, LAGET has positioned itself as a key actor within the One Health paradigm in Chad and the Central African region, and it is now part of the laboratory network of the National Public Health Institute of Chad.
Transitioning the COVID-19 response in the WHO African region: a proposed framework for rethinking and rebuilding health systems | BMJ Global Health [Internet]. [cited 2025 Jul 6]. Available from: https://gh.bmj.com/content/7/12/e010242?utm_source=chatgpt.com
Janssen S, Huson MA, Bélard S, Stolp S, Kapata N, Bates M, et al. TB and HIV in the Central African region: current knowledge and knowledge gaps. Infection 2014;42:281-94.
Oyono MG, Kenmoe S, Abanda NN, Takuissu GR, Ebogo-Belobo JT, Kenfack-Momo R, et al. Epidemiology of yellow fever virus in humans, arthropods, and non-human primates in sub-Saharan Africa: A systematic review and meta-analysis. PLOS Negl Trop Dis 2022;16:e0010610.
Poungou N, Sevidzem SL, Koumba AA, Koumba CRZ, Mbehang P, Onanga R, et al. Mosquito-Borne Arboviruses Occurrence and Distribution in the Last Three Decades in Central Africa: A Systematic Literature Review. Microorganisms 2023;12:4.
Mettenleiter TC, Markotter W, Charron DF, Adisasmito WB, Almuhairi S, Behravesh CB, et al. The One Health High-Level Expert Panel (OHHLEP). One Health Outlook 2023;5:18.
International Health Regulations (2005) – Third edition [Internet]. [cited 2025 Jul 6]. Available from: https://www.who.int/publications/i/item/9789241580496
Mennechet F, Andreoletti L, Cappelli G, Fokam J, Kuiate JR, Moussa AM, et al. Launch of the Laboratory for Major Tropical Epidemics (LAGET) in Chad: Strengthening the capacity for epidemiological surveillance, monitoring and diagnosis of endemic or emerging infectious diseases in Central Africa. J Public Health Afr 2022;13:4.
Hota M, Wondeu ALD, Abakar MF, Dezoumbe K, Abdelrazakh F, Atturo S, et al. Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N′Djamena: Insights Into Chad’s COVID-19 Epicenter. J Med Virol 2025;97:e70234.
Dezoumbe K, Djarma O, Wondeu ALD, Zakaria FA, Atturo S, Naïbeï N, et al. SARS-CoV-2 seroprevalence and associated factors among outpatient attendees at health facilities in different provinces in Chad. BMC Infect Dis 2024;24:1271.
Chable de la Héronnière F, Barthelemy J, Dzomo GRT, Abdelrazakh F, Djarma O, Auguste L, et al. Evidence of Zika virus circulation in human and livestock in Chad. Virus Res 2024;350:199492.
Frontiers | Predictors of COVID-19 vaccine hesitancy in Chad: A cross-sectional study [Internet]. [cited 2025 Jul 6]. Available from: https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.1063954/full
Hota M, Fissou H, Koutaya D, Djimtoïbaye D, Ali M. Genomic Profile of SARS-COV-2 Associated with COVID-19 Outbreaks in N’Djamena, Chad. Adv Biosci Biotechnol 2024;15:432-42.
Wondeu ALD, Abakar MF, Frasca F, Nodjikouambaye AZ, Abdelrazakh F, Naibei N, et al. Presence of neutralizing SARS-CoV-2 antibodies in asymptomatic population of N'Djamena, Chad. Immun Inflamm Dis 2024;12:e1154.
Wondeu ALD, Abdelrazakh F, Abakar MF, Yandai FH, Nodjikouambaye AZ, Djimtoibaye D, et al. High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad. J Public Health Afr 2022;13:12.
De Oliveira T, Wilkinson E, Baxter C, Tegally H, Giandhari J, Naidoo Y, et al. Building genomic sequencing capacity in Africa to respond to the SARS-CoV-2 pandemic. Science 2022.
World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations. Vaccine 2019;37:223-5.
World Health Organization. Maintaining essential health services: operational guidance for the COVID-19 context: interim guidance, 1 June 2020 [Internet]. [cited 2025 Jul 6]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-essential_health_services-2020.2
Chable de la Héronnière F, Barthelemy J, Dzomo GRT, Abdelrazakh F, Djarma O, Auguste L, et al. Evidence of Zika virus circulation in human and livestock in Chad. Virus Res 2024;350:199492.
Sullivan A, Ogunseitan O, Epstein J, Kuruchittham V, Nangami M, Kabasa D, et al. International stakeholder perspectives on One Health training and empowerment: a needs assessment for a One Health Workforce Academy. One Health Outlook 2023;5:8.
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. N Engl J Med 2016;374.
How to Cite
Dezoumbe, K., Suitombaye, N. Y., Routoubé, M., Akouya, A., Dafogo Djibagaou, A., Atturo, S., … Mennechet, F. J. (2025). Four years after its creation: what role for the <i>Laboratoire des Grandes Épidémies Tropicales</i> (LAGET) in epidemic response in Chad?. Sahelian Journal of Responsible One Health, 1(1). Retrieved from https://africa.pagepress.net/sjroh/article/view/538
Copyright (c) 1970 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.